Clinical trial / 2010
D-psicose lowered postprandial blood glucose mainly in borderline diabetes and showed 12-week safety
In a randomized crossover trial of 26 adults including borderline diabetes patients, five grams of D-psicose taken with a meal lowered blood glucose at 30 and 60 minutes (p<0.01, p<0.05) and reduced glucose area under the curve (p<0.01), primarily in borderline diabetes cases. In a 12-week parallel trial of 17 normal subjects taking five grams three times daily, no abnormal effects or clinical problems were observed.
- Study type
- Randomized controlled trials
- Who was studied
- 26 adults (including borderline diabetes patients) and 17 normal subjects
- What was measured
- Postprandial blood glucose and clinical safety variables
THE PAPER
Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects.
Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. Biosci Biotechnol Biochem, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.